|
Nitroso Furosemide
|
|
1
|
890
|
May 20, 2023
|
|
Nitrosamines in ICH S9
|
|
8
|
1546
|
May 15, 2023
|
|
AI for NDSRIs of Terbinafin hydrochloride and Impurity A
|
|
4
|
929
|
May 14, 2023
|
|
EFPIA Position paper for NDSRIs of beta-blockers and beta-agonists / ACE inhibitors / dihydropyridine
|
|
1
|
1336
|
April 24, 2023
|
|
N-Nitrosobupropion
|
|
4
|
1536
|
April 10, 2023
|
|
Theoretical 'Purge Factor'
|
|
10
|
2289
|
March 31, 2023
|
|
Unofficial/official surrogates for read-across
|
|
5
|
2100
|
March 27, 2023
|
|
Officially used surrogates for read-across method
|
|
14
|
2920
|
March 23, 2023
|
|
NDSRI complex nitrosamine Accetable Intake methodology harmonisation by regulators may be followed in Early 2024
|
|
1
|
974
|
March 14, 2023
|
|
Limit for Nitroso Atenolol
|
|
6
|
1584
|
March 14, 2023
|
|
确定DNSRI的限度需要同时进行Ames和致癌性实验吗？
|
|
4
|
563
|
March 2, 2023
|
|
A temporary AI (t-AI) of 178 ng/day (total nitrosamines) - EMA
|
|
7
|
1576
|
January 30, 2023
|
|
Nitroso-Sitagliptin Who/Where/Limit?
|
|
22
|
4766
|
January 26, 2023
|
|
Nitrosamines in solution at pH 7
|
|
4
|
1000
|
January 20, 2023
|
|
Limit for Nitroso Ramipril
|
|
1
|
1112
|
January 13, 2023
|
|
Nitroso-Abacavir
|
|
4
|
651
|
January 6, 2023
|
|
What could be the basis of choice for different TD50s for different nitrosamines by regulatory authorities
|
|
0
|
437
|
December 16, 2022
|
|
Cleaning Validations Criteria
|
|
1
|
1789
|
December 5, 2022
|
|
Setting limits for N-nitrosamines: read-across and structure-activity relationship for N-nitrosopiperazine impurities
|
|
0
|
618
|
November 17, 2022
|
|
What Makes a Potent Nitrosamine? Statistical Validation of Expert SAR
|
|
0
|
494
|
October 28, 2022
|
|
AI for small nitrosamines not listed in EMA, FDA or Health Canada
|
|
10
|
1534
|
October 13, 2022
|
|
Selection of MDD in Finished product
|
|
1
|
598
|
October 5, 2022
|
|
AI for Nitroso-Duloxetine
|
|
5
|
1571
|
September 3, 2022
|
|
Limite de Nitrosaminas en Metformina Materia Prime y Producto Terminado
|
|
5
|
686
|
August 30, 2022
|
|
Nitroso mono desethyl amiodarone
|
|
0
|
461
|
August 26, 2022
|
|
Calculando Limites de carcinogenicos: AI, PDE, y LTL
|
|
0
|
401
|
August 23, 2022
|
|
Valsartan & Hydrochlorothiazide related NDSRIs
|
|
4
|
787
|
August 5, 2022
|
|
Nitroso Flecainide
|
|
9
|
1589
|
July 14, 2022
|
|
Harmonization of AI for NDSRIs with insufficient carcinogenic data
|
|
5
|
1105
|
July 14, 2022
|
|
BMDL vs TD50 Consideration When? How?
|
|
3
|
424
|
July 7, 2022
|